Related Experiment Videos
Development of an opioid-taper algorithm for hematopoietic cell transplant recipients
1Blood and Marrow Transplant Department, Fairview University Medical Center, Minneapolis, MN, USA. lparran1@fairview.org
Oncology Nursing Forum
|August 2, 2000
Summary
Hematopoietic cell transplant (HCT) patients often require opioid therapy and can experience withdrawal. This study developed an opioid taper algorithm to guide clinicians and improve patient comfort during opioid discontinuation.
Area of Science:
- Oncology Nursing
- Hematology
- Pharmacology
Background:
- Hematopoietic cell transplant (HCT) recipients frequently receive prolonged opioid therapy.
- Physical dependence on opioids is common in HCT patients, necessitating careful management upon discontinuation.
Purpose of the Study:
- To develop and describe a novel opioid taper algorithm specifically for hematopoietic cell transplant recipients.
- To address the lack of research-based, HCT-specific guidelines for opioid tapering.
Main Methods:
- Synthesized information from non-research-based guidelines and published research on opioid withdrawal.
- Incorporated clinical experience and recommendations from multidisciplinary consultants.
Main Results:
- Identified a significant need for structured opioid tapering protocols in HCT patients to prevent withdrawal symptoms.
- The developed algorithm provides a flexible framework for managing opioid discontinuation, accommodating individual patient needs and discomfort levels.
Conclusions:
- Existing opioid tapering guidelines are not specific to HCT recipients and lack standardization.
- The proposed algorithm fills a critical gap in the literature, promoting consistent and comfortable opioid tapering for HCT patients.